Citations

Mayo Clinic

Showing 10 of 108572 citations.

Mycobacteria
Simner, Patricia J. , Woods, Gail L. , Wengenack, Nancy L.

Microbiology Spectrum | October 11, 2016 | Volume: 4 | Issue: 4 | Pages: No page available

10.1128/microbiolspec.dmih2-0016-2015 | PMID 27726808 Get It

ABSTRACT The immunocompromised host is at increased risk of Mycobacterium tuberculosis complex and nontuberculous mycobacteria infection. Although Mycobacterium tuberculosis complex is a significant mycobacterial pathogen, nontuberculous mycobacteria causes substantial disease in those with suppressed immune responses. Mycobacterial infections can cause significant morbidity and mortality in this patient population, and rapid identification and susceptibility testing of the mycobacterial species is paramount to patient management and outcomes. Mycobacterial diagnostics has undergone some significant advances in the last two decades with immunodiagnostics (interferon gamma release assay), microscopy (light-emitting diode), culture (automated broth-based systems), identification (direct PCR, sequencing and matrix-assisted laser-desorption ionization–time of flight mass spectrometry) and susceptibility testing (molecular detection of drug resistance from direct specimens or positive cultures). Employing the most rapid and sensitive methods in the mycobacterial laboratory will have a tremendous impact on patient care and, in the case of Mycobacterium tuberculosis complex, in the control of tuberculosis.
Parasites
Theel, Elitza S. , Pritt, Bobbi S. , Pritt, Bobbi S

Microbiology Spectrum | October 11, 2016 | Volume: 4 | Issue: 4 | Pages: No page available

10.1128/microbiolspec.dmih2-0013-2015 | PMID 27726821 Get It

ABSTRACT Parasites are an important cause of human disease worldwide. The clinical severity and outcome of parasitic disease is often dependent on the immune status of the host. Specific parasitic diseases discussed in this chapter are amebiasis, giardiasis, cryptosporidiosis, cyclosporiasis, cystoisosporiasis, microsporidosis, granulomatous amebic encephalitis, toxoplasmosis, leishmaniasis, Chagas disease, malaria, babesiosis, strongyloidiasis, and scabies.
Responsiveness of 8 Patient‐Reported Outcomes Measurement Information System (PROMIS) measures in a large, community‐based cancer study cohort
Moinpour, Carol M. , Potosky, Arnold L. , Lobo, Tania , Hahn, Elizabeth A. , Hays, Ron D. , Cella, David , Keegan, Theresa H.M. , Paddock, Lisa E. , Stroup, Antoinette M. , Eton, David T. , Jensen, Roxanne E. , Smith, Ashley Wilder , Wu, Xiao‐Cheng

Cancer | October 11, 2016 | Volume: 123 | Issue: 2 | Pages: 327-335

10.1002/cncr.30354 | PMID 27696377 Get It

BACKGROUND The Patient‐Reported Outcomes Measurement Information System (PROMIS) was a National Institutes of Health‐funded initiative to develop measures of symptoms and function. Responsiveness is the degree to which a measure can detect underlying changes over time. The objective of the current study was to document the responsiveness of 8 PROMIS measures in a large, population‐based cancer cohort. METHODS The Measuring Your Health study recruited 2968 patients who were diagnosed with 1 of 7 cancers between 2010 and 2012 through 4 Surveillance, Epidemiology, and End Results registries. Participants completed a baseline survey (6‐13 months after diagnosis) and a 6‐month follow‐up survey. Changes in 8 PROMIS scores were compared with global ratings of transition, changes in performance status, and clinical events. RESULTS Measures were responsive to 6‐month declines and improvements in performance status with small to large effect sizes (ES) (Cohen d = 0.34‐0.71; P < .01). Mean changes and effect sizes were larger for participants who reported declines compared with those who reported improvements. Small‐to‐medium ES were observed in patients who reported being “a little” worse (d = 0.31‐0.56), and medium‐to‐large ES were observed in those who reported being “a lot” worse (d = 0.53‐0.72). Hospitalized participants reported significant score increases, resulting in worsening of pain (d = 0.51), fatigue (d = 0.35), and depression (d = 0.57; all P < .01). Cancer recurrence and progression were associated with smaller increases in pain, fatigue, and sleep disturbance (d = 0.22‐0.27). CONCLUSIONS The current results indicated that all 8 PROMIS measures were sensitive to patient‐perceived worsening and improvement and to major clinical events. These findings will be able to inform the design and interpretation of future research studies and clinical initiatives administering PROMIS measures. Cancer 2017;123:327–335. © 2016 American Cancer Society .
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy
Goss, Paul E. , Shepherd, Lois E. , Chapman, J. W. , Chen, Bingshu E. , Kubo, Michiaki , Furukawa, Yoichi , Momozawa, Yukihide , Stearns, Vered , Barman, Poulami , Weinshilboum, Richard M. , Kalari, Krishna R. , Wang, Liewei , Xie, Fang , Ingle, James N. , Xie, Fang , Ellis, Matthew J. , Chapman, Judith‐Anne W. , Pritchard, Kathleen I. , Carlson, Erin E. , Goetz, Matthew P. , Weinshilboum, Richard M. , Stearns, Vered , Chen, Bingshu E , Kalari, Krishna R

Cancer Research | October 11, 2016 | Volume: 76 | Issue: 23 | Pages: 7012-7023

10.1158/0008-5472.can-16-1371 | PMID 27758888 Get It

Abstract Genetic risks in breast cancer remain only partly understood. Here, we report the results of a genome-wide association study of germline DNA from 4,658 women, including 252 women experiencing a breast cancer recurrence, who were entered on the MA.27 adjuvant trial comparing the aromatase inhibitors (AI) anastrozole and exemestane. Single-nucleotide polymorphisms (SNP) of top significance were identified in the gene encoding MIR2052HG, a long noncoding RNA of unknown function. Heterozygous or homozygous individuals for variant alleles exhibited a ∼40% or ∼63% decrease, respectively, in the hazard of breast cancer recurrence relative to homozygous wild-type individuals. Functional genomic studies in lymphoblastoid cell lines and ERα-positive breast cancer cell lines showed that expression from MIR2052HG and the ESR1 gene encoding estrogen receptor-α (ERα) was induced by estrogen and AI in a SNP-dependent manner. Variant SNP genotypes exhibited increased ERα binding to estrogen response elements, relative to wild-type genotypes, a pattern that was reversed by AI treatment. Further, variant SNPs were associated with lower expression of MIR2052HG and ERα. RNAi-mediated silencing of MIR2052HG in breast cancer cell lines decreased ERα expression, cell proliferation, and anchorage-independent colony formation. Mechanistic investigations revealed that MIR2052HG sustained ERα levels both by promoting AKT/FOXO3-mediated ESR1 transcription and by limiting ubiquitin-mediated, proteasome-dependent degradation of ERα. Taken together, our results define MIR2052HS as a functionally polymorphic gene that affects risks of breast cancer recurrence in women treated with AI. More broadly, our results offer a pharmacogenomic basis to understand differences in the response of breast cancer patients to AI therapy. Cancer Res; 76(23); 7012–23. ©2016 AACR.
The Value of MRI and Clinical Features in Differentiating Between Cellular and Fibrous Solitary Fibrous Tumors
Nagata, Shuji , Amrami, Kimberly K. , Tonan, Tatsuyuki, Fujimoto, Kiminori , Abe, Toshi , Nishimura, Hiroshi , Akiba, Jun

American Journal of Roentgenology | October 11, 2016 | Volume: 208 | Issue: 1 | Pages: 10-17

10.2214/ajr.16.16423 | PMID 27726413 Get It

Urinary collecting system invasion is associated with poor survival in patients with clear‐cell renal cell carcinoma
Bailey, George C., Boorjian, Stephen A. , Ziegelmann, Matthew , Westerman, Mary E. , Lohse, Christine M. , Leibovich, Bradley C. , Cheville, John C. , Thompson, R. Houston, Ziegelmann, Matthew J, Westerman, Mary E

BJU International | October 11, 2016 | Volume: 119 | Issue: 4 | Pages: 585-590

10.1111/bju.13669 | PMID 27696652 Get It

Objectives To evaluate the prognostic significance of urinary collecting system invasion ( UCSI ) in a large series of patients with clear‐cell renal cell carcinoma ( RCC ). Materials and Methods Patients with clear‐cell RCC treated with nephrectomy between 2001 and 2010 were reviewed from a prospectively maintained registry. One urological pathologist re‐reviewed all slides. Cancer‐specific survival was estimated using the Kaplan–Meier method, and associations of UCSI with death from RCC were evaluated using Cox models. Results Of the 859 patients with clear‐cell RCC , 58 (6.8%) had UCSI . At last follow‐up, 310 patients had died from RCC at a median of 1.8 years after surgery. The median follow‐up for patients alive at last follow‐up was 8.2 years. The estimated cancer‐specific survival at 10 years after surgery for patients with UCSI was 17%, compared with 60% for patients without UCSI ( P < 0.001). In a multivariable model, UCSI remained independently associated with an increased risk of death from RCC (hazard ratio 1.5; P = 0.018). Further, among patients with pT 3 RCC , those with USCI had survival outcomes similar to those of patients with pT 4 RCC. Conclusions Collecting system invasion is associated with poor prognosis among patients with clear‐cell RCC . If validated, consideration should be given to including UCSI in future staging systems.
Cytomegalovirus
Dioverti, M. Veronica , Razonable, Raymund R. , Dioverti, Maria Veronica

Microbiology Spectrum | October 11, 2016 | Volume: 4 | Issue: 4 | Pages: No page available

10.1128/microbiolspec.dmih2-0022-2015 | PMID 27726793 Get It

ABSTRACT Cytomegalovirus (CMV), the largest of the herpesviruses, causes a wide range of clinical syndromes, from asymptomatic infection to severe disease in immunocompromised hosts. Laboratory methods for diagnosis include molecular testing, antigenemia, culture, serology, and histopathology. Treatment of CMV infection and disease is indicated in selected immunocompromised hosts, and preventive approaches are indicated in high-risk groups. This chapter reviews the epidemiology, clinical aspects, and the laboratory diagnosis and management of CMV in immunocompromised hosts.
Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care
Apple, Fred S. , Sandoval, Yader , Jaffe, Allan S. , Ordóñez‐Llanos, Jordi , Jaffe, Allan S.

Clinical Chemistry | October 11, 2016 | Volume: 63 | Issue: 1 | Pages: 73-81

10.1373/clinchem.2016.255109 | PMID 28062612 Get It

Abstract BACKGROUND Cardiac troponin I (cTnI) and cardiac troponin T (cTnT) determinations are fixtures in clinical practice and research. Cardiac troponin testing has been the standard of practice for the diagnosis of acute myocardial infarction (AMI), early rule-out, risk stratification, and outcomes assessment in patients presenting with acute coronary syndrome (ACS) and non-ACS myocardial injury. We recognize from reading the literature over the past several years how poorly understood the analytical characteristics are for cTnI and cTnT assays by laboratorians, clinicians, and scientists who use these assays. CONTENT The purposes of this mini-review are (a) to define limit of blank, limit of detection, limit of quantification, and imprecision, (b) overview the analytical characteristics of the existing cardiac troponin assays, (c) recommend approaches to define a healthy (normal) reference population for determining the 99th percentile and the appropriate statistic to use for this calculation, (d) clarify how an assay becomes designated as “high sensitivity,” and (e) provide guidance on determining delta (Δ) change values. SUMMARY This review raises important educational information regarding cTnI and cTnT assays, their 99th percentile upper reference limits (URL) differentiated by sex, and specifically addresses high-sensitivity (hs)-assays used to measure low concentrations. Recommendations are made to help clarify the nomenclature and analytical and clinical characteristics to define hs-assays. The review also identifies challenges for the evolving implementation of hs-assays into clinical practice. It is hoped that with the introduction of these concepts, laboratorians, clinicians and researchers can develop a more unified view of how these assays should be used worldwide.
Natriuretic Peptides and Analytical Barriers
Vasile, Vlad C. , Jaffe, Allan S. , Jaffe, Allan S.

Clinical Chemistry | October 11, 2016 | Volume: 63 | Issue: 1 | Pages: 50-58

10.1373/clinchem.2016.254714 | PMID 28062611 Get It

Abstract BACKGROUND The natriuretic peptide system is an endocrine, autocrine and paracrine system that plays an important role in the maintenance of cardiovascular homeostasis. Biomarkers based on these peptides are important diagnostic and prognostic tools for myocardial function. CONTENT Although natriuretic peptides were discovered more than 2 decades ago, their intricate and complex biology is associated with important questions not yet elucidated. The diversity of circulating forms of natriuretic peptides, the distinct expression of these forms in particular patients, and the heterogeneity of heart failure forms, along with specific assay-related and preanalytic issues, cause assays to be poorly harmonized. SUMMARY This review presents the relevant issues related to the biology of natriuretic peptides and differences between assays with immediate implications for clinical practice.
The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade Students
Starling, Amaal J. , Wethe, Jennifer V. , Messner, Leonard V., Master, Christina L. , Halker-Singh, Rashmi B., Vargas, Bert B., Bogle, Jamie M. , Mandrekar, Jay , Talaber, Alexandra , Leong, Danielle, Dodick, David, Wethe, Jennifer, Dodick, David W. , Pang, Yi , Smith, Craig E. , Wethe, Jennifer V

Journal of Child Neurology | October 11, 2016 | Volume: 32 | Issue: 1 | Pages: 104-111

10.1177/0883073816668704 | PMID 28257277 Get It

Efficient eye movements provide a physical foundation for proficient reading skills. We investigated the effect of in-school saccadic training on reading performance. In this cross-over design, study participants (n = 327, 165 males; mean age [SD]: 7 y 6 mo [1y 1 mo]) were randomized into treatment and control groups, who then underwent eighteen 20-minute training sessions over 5 weeks using King-Devick Reading Acceleration Program Software. Pre- and posttreatment reading assessments included fluency, comprehension, and rapid number naming performance. The treatment group had significantly greater improvement than the control group in fluency (6.2% vs 3.6%, P = .0277) and comprehension (7.5% vs 1.5%, P = .0002). The high-needs student group significantly improved in fluency ( P < .001) and comprehension ( P < .001). We hypothesize these improvements to be attributed to the repetitive practice of reading-related eye movements, shifting visuospatial attention, and visual processing. Consideration should be given to teaching the physical act of reading within the early education curriculum.